Literature DB >> 16014058

Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan.

Chin-Hsiao Tseng1.   

Abstract

BACKGROUND: Uric acid is detrimental to the kidneys in animal models. However, its role in human diabetic nephropathy has not been extensively studied. This study evaluated the association between serum uric acid and urinary albumin-to-creatinine ratio (ACR) among patients with type 2 diabetes mellitus in Taiwan.
METHODS: A total of 343 patients (144 men and 199 women), aged 62.8 +/- 10.8 years and not using uric acid-lowering agents, diuretics, or alcohol, were recruited. Serum uric acid and urinary ACR were determined. Normoalbuminuria, microalbuminuria, and macroalbuminuria were defined as ACR <30.0, 30.0 to 299.9, and > or =300.0 microg/mg, respectively.
RESULTS: The respective uric acid levels for normoalbuminuria (N= 166), microalbuminuria (N= 130), and macroalbuminuria (N= 47) were 5.2 +/- 1.6 mg/dL, 5.6 +/- 1.9 mg/dL, and 6.7 +/- 2.1 mg/dL (P < 0.001). The mean +/- SD (minimum-maximum) values of uric acid for the first to the fourth quartile were 3.4 +/- 0.6 (1.7-4.2), 4.9 +/- 0.4 (4.3-5.4), 6.0 +/- 0.3 (5.5-6.5), and 8.1 +/- 1.2 (6.6-12.2), respectively. Prevalence of abnormal albuminuria (microalbuminuria plus macroalbuminuria) for the respective quartiles were 38.4%, 51.2%, 50.6%, and 66.3% (P trend <0.01). In men, uric acid correlated positively with triglycerides and natural logarithmic [ln (ACR)] (gamma= 0.168, P < 0.05). In women, uric acid correlated positively with triglycerides, ln (ACR) (gamma= 0.277, P < 0.01) and body mass index (borderline significant P < 0.1), but negatively with calculated creatinine clearance. The standardized regression coefficient for ln (ACR) and the odds ratio for abnormal albuminuria for every 1 mg/dL increment of uric acid after adjusting for calculated creatinine clearance and other confounders were 0.138 (P < 0.05) and 1.183 (1.025-1.364), respectively. The results after excluding 127 cases with a history of hypertension were similar.
CONCLUSION: Serum uric acid is an independent correlate of urinary ACR in Taiwanese patients with type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014058     DOI: 10.1111/j.1523-1755.2005.00459.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

Review 2.  Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.

Authors:  Kunal Chaudhary; Kunal Malhotra; James Sowers; Annayya Aroor
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

Review 3.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

Review 4.  Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.

Authors:  Chun Hu; Xiaoyan Wu
Journal:  Int Urol Nephrol       Date:  2019-08-28       Impact factor: 2.370

Review 5.  The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review.

Authors:  G Zoppini; G Targher; E Bonora
Journal:  J Endocrinol Invest       Date:  2011-12       Impact factor: 4.256

6.  High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

Authors:  Elizabeth T Rosolowsky; Linda H Ficociello; Nicholas J Maselli; Monika A Niewczas; Amanda L Binns; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

7.  Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

Authors:  Tomoki Kosugi; Takahiro Nakayama; Marcelo Heinig; Li Zhang; Yukio Yuzawa; Laura Gabriela Sanchez-Lozada; Carlos Roncal; Richard J Johnson; Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-20

8.  Association of a polymorphism in a gene encoding a urate transporter with CKD progression.

Authors:  Alessandra Testa; Francesca Mallamaci; Belinda Spoto; Anna Pisano; Maria Cristina Sanguedolce; Giovanni Tripepi; Daniela Leonardis; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 8.237

9.  Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Authors:  E Ritz; G C Viberti; L M Ruilope; A J Rabelink; J L Izzo; S Katayama; S Ito; A Mimran; J Menne; L C Rump; A Januszewicz; H Haller
Journal:  Diabetologia       Date:  2009-10-30       Impact factor: 10.122

Review 10.  The conundrum of hyperuricemia, metabolic syndrome, and renal disease.

Authors:  Takahiko Nakagawa; Pietro Cirillo; Waichi Sato; Michael Gersch; Yuri Sautin; Carlos Roncal; Wei Mu; L Gabriela Sánchez-Lozada; Richard J Johnson
Journal:  Intern Emerg Med       Date:  2008-03-05       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.